دورية أكاديمية
1051P Clinical experience of tabelecleucel in patients with EBV+ primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease
العنوان: | 1051P Clinical experience of tabelecleucel in patients with EBV+ primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease |
---|---|
المؤلفون: | Nikiforow, S., Baiocchi, R., Nasta, S., Weng, W., Loeb, D., Mahadeo, K.M., Whangbo, J., Phuong, P., Navarro, W., Gamelin, L., Sun, Y., Guzman-Becerra, N., Prockop, S. |
المصدر: | In Annals of Oncology September 2020 31 Supplement 4:S719-S719 |
قاعدة البيانات: | ScienceDirect |
تدمد: | 09237534 |
---|---|
DOI: | 10.1016/j.annonc.2020.08.1171 |